when does aphria report earnings
Source: istock, Aphria

Aphria’s Upcoming Earnings, Analysts Recommend a Buy


Oct. 13 2020, Updated 9:26 a.m. ET

Aphria is set to release its earnings report for the first quarter of fiscal 2021, which ended Aug. 31, before the market opens on Oct. 15. Let’s look at analysts’ expectations for the first quarter.

Article continues below advertisement

When is Aphria’s earnings date?

Aphria will likely release its earnings for the first quarter of fiscal 2021 early on Oct. 15. The cannabis company has scheduled a conference call with investors and analysts on the same day at 9:00 a.m. ET.

aphria medical cannabis
Source: istock
Article continues below advertisement

Aphria is a Canada-based cannabis company founded in 2014. The company engages in the production and supply of medical cannabis. Aphria has been struggling to generate profits and achieve financial targets. 

In the first quarter, Wall Street analysts expect Aphria to post sales of 159.7 million Canadian dollars, which would be 26.7 percent higher than 126.1 million Canadian dollars in sales in the first quarter of fiscal 2020. Analysts also expect the company to report an adjusted EPS of -0.04 Canadian dollars in the first quarter compared to 0.07 in the same period a year ago.

Article continues below advertisement

What is Aphria’s stock price?

Aphria stock is traded on Nasdaq under the ticker symbol “APHA.” The stock was down about 3.9 percent at $6.12 in the pre-market trading session on Tuesday, Oct. 13, as of 7:54 a.m. ET. The stock rose 10.8 percent on Oct. 12 and closed at $6.37 with a market capitalization of $1.65 billion.

aphria earnings
Source: istock
Article continues below advertisement

Aphria stock has risen by 29.7 percent in the last five days and 17.3 percent in the last year. The stock is trading 1.1 percent below its 52-week high of $6.44 and 226.7 percent above its 52-week low of $1.95. Aphria doesn’t pay a dividend.

What is Aphria’s stock forecast?

Currently, analysts' stock price forecast for Aphria is $7.69, which suggests a 20.7 percent upside. The highest target price of $11.80 implies an 85.2 percent upside, while the lowest target price of $6.09 suggests a 4.4 percent downside. All of the eight Wall Street analysts tracking Aphria recommend a buy. None of the analysts recommend a sell. 

Article continues below advertisement

Aphria's investor relations

Aphria has scheduled a first-quarter earnings conference call on Oct. 15 at 9:00 a.m. ET. Analysts and investors can attend the webcast through the investor relations section of the company’s website. The event can also be accessed by dialing (888) 231-8191 from Canada and the U.S. or (647) 427-7450 from International locations. The passcode is 5693063.


More From Market Realist

  • Flora Growth logo and woman looking at marijuana plants
    What to Expect From the Flora Growth IPO This Week
  • Trulieve and Harvest Health logos over marijuana
    Trulieve Acquires Harvest Health in Multi-Billion Dollar Deal
  • Tilray logo over marijuana harvest
    Is Tilray (TLRY) Stock a Good Buy? According to Jefferies, Yes
  • Marijuana plant
    What the Tilray and Aphria Merger Means for Investors
  • CONNECT with Market Realist
  • Link to Facebook
  • Link to Twitter
  • Link to Instagram
  • Link to Email Subscribe
Market Realist Logo
Do Not Sell My Personal Information

© Copyright 2021 Market Realist. Market Realist is a registered trademark. All Rights Reserved. People may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.